| ID | Analyse | Domein | Recipiënt | Uitvoering | LTAT (uren (dagen)) | Accred. | LOINCeenheid (1) | LOINCeenheid (2) | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 22379 | Ammoniak | EDTA |
maandag t/m vrijdag | 4 (0,2) | – | 32664-5 ug/dL | 1839-0 umol/L | › | ||
| 26910 | Amylase | Urine |
maandag t/m vrijdag | 26 (1,1) | – | 1799-6 U/L | – | › | ||
| 28794 | Amylase | Punctievocht (Ascites / Pleura / Pericard) |
maandag t/m vrijdag | – | 1795-4 U/L | – | › | |||
| 22400 | Amylase | Serum |
maandag t/m vrijdag | 1 (0,1) | B | 1798-8 U/L | – | › | ||
| 26926 | Amylase/creatinine clear. Amylase/creatinine klaring | Serum Urine |
122 (5,1) | – | – | – | › | |||
| 23140 | ANA (HEp-2, 1/80) ANA, ANF, Antinucleaire antilichamen | Serum |
maandag t/m vrijdag | 72 (3) | B | 59069-5 | – | › | ||
| 71210 | Ananas f210 IgG | Serum |
2× per week, op dinsdag en vrijdag | – | – mgA/l | – | › | |||
| 4390 | Anaplasma phagocytophilum | Serum |
– | – | – | › | ||||
| 23260 | ANCA/MPO/PR3 diagnose Anti-MPO, Anti-Myeloperoxidase, Anti-PR3 | Serum |
65 (2,7) | – | 46266-3 | – | › | |||
| 90550 | Ander | Biopsie |
78 (3,2) | – | – | – | › | |||
| ● 34353 | Androstaandiolglucuronide 3 alfa-diol glucuronide, 5 alfa-androstaan-3 alfa-17 beta-diol-glucuronide, 5 alfa-androstane-3 alfa-17 beta-diol-glucuronide | Serum |
2× per week | – | 1680-8 ng/mL | 15008-6 nmol/L | › | |||
| 57120 | Androsteendion Delta-4-androsteendion | Serum |
3× per week | 145 (6) | – | – ng/dL | 14603-5 nmol/L | › | ||
| 22652 | Angiotensine conv. enzym ACE, Kininase II | Serum |
maandag t/m vrijdag | 22 (0,9) | – | 2742-5 U/L | – | › | ||
| 22141 | Aniongap | Serum |
1 (0) | – | – | – | › | |||
| 4328 | Anisakis (ELISA) Haringwormziekte antistoffen | Serum |
1× per 2 weken | 197 (8,2) | – | – | – | › | ||
| 23337 | Anti-Aquaporine-4 (1/1) Anti-NMO (1/1) | Lumbaalvocht (CSV) |
1× per 1–2 weken | 129 (5,4) | – | – | – | › | ||
| 23282 | Anti-Aquaporine-4 (1/10) Anti-NMO (1/10) | Serum |
1× per 1–2 weken | 46 (1,9) | – | 43638-6 | – | › | ||
| 23338 | Anti-Aquaporine-4 titer | Lumbaalvocht (CSV) |
– | – | – | › | ||||
| 23336 | Anti-Aquaporine-4 titer | Serum |
99 (4,1) | – | 95273-9 | – | › | |||
| 23332 | Anti-beta2 glycoproteïne | Serum |
57 (2,4) | – | – | – | › | |||
| 23308 | Anti-cardiolipine IgG Anti-fosfolipiden antistoffen, Cardiolipine IgG | Serum |
maandag t/m vrijdag | 26 (1,1) | – | 3181-5 GPL U/ml | – | › | ||
| 23307 | Anti-cardiolipine IgM Anti-fosfolipiden antistoffen, Cardiolipine IgM | Serum |
maandag t/m vrijdag | 26 (1,1) | – | 3182-3 MPL U/ml | – | › | ||
| 23138 | Anti-CCP Anti-Cyclic Citrullinated Peptide, Cyclic Citrullinated Peptide Antibody, Cyclisch gecitrullineerde peptiden | Serum |
maandag t/m vrijdag | 3 (0,1) | – | 53027-9 U/ml | – | › | ||
| 24006 | Anti-Endomysium IgA 1/10 | Serum |
tenminste 1× per week | 156 (6,5) | – | 46126-9 | – | › | ||
| 24021 | Anti-Endomysium IgG 1/10 | Serum |
tenminste 1× per week | 26 (1,1) | – | 39554-1 | – | › | ||
| 1342 | anti-factor Xa | Citraat |
1× per week | 96 (4) | – | 3216-9 IU/ml | – | › | ||
| 22591 | anti-GAD Anti Glutamic Acid Decarboxylase 65 antistoffen, GAD65 antistoffen, GADA | Serum |
1× per 1–2 weken | 175 (7,3) | – | 56540-8 IU/mL | – | › | ||
| 3258 | anti-ganglioside AS | Serum |
667 (27,8) | – | 82455-7 | – | › | |||
| 24000 | Anti-gliadine DP IgA Gedeamideerde gliadine IgA | Serum |
maandag t/m vrijdag | 10 (0,4) | – | 63453-5 U/ml | – | › | ||
| 24002 | Anti-gliadine DP IgG Gedeamideerde gliadine IgG | Serum |
maandag t/m vrijdag | 7 (0,3) | – | 58710-5 U/ml | 20496-6 U/ml | › | ||
| 3306 | anti-glycine receptor As | Serum |
319 (13,3) | – | 95722-5 | – | › | |||
| 24496 | anti-HBs na 4 weken HBV surface antistoffen na 4 weken | Serum |
maandag t/m vrijdag | 1 (0) | B | – mIU/mL | – | › | ||
| 24499 | anti-HBs na booster HBV surface antistoffen na booster | Serum |
1 (0,1) | B | – mIU/mL | – | › | |||
| 24506 | anti-HBs na booster 5 | Serum |
1 (0) | – | – mIU/mL | – | › | |||
| 24497 | anti-HBs voor booster HBV surface antistoffen voor booster | Serum |
1 (0,1) | B | – mIU/mL | – | › | |||
| 3314 | Anti-histonen | Serum |
– | 17380-7 U/ml | – | › | ||||
| 2592 | anti-IA2 antilichamen | Serum |
1× per maand | 909 (37,9) | – | 31209-0 U/mL | – | › | ||
| 23206 | Anti-intrinsic factor IgG Anti-intrisic factor antistoffen, Intrisic factor antistoffen | Serum |
maandag t/m vrijdag | 34 (1,4) | – | 56539-0 U/mL | – | › | ||
| 3242 | anti-MAG As Myeline geassocieerde glycoproteïne antistoffen | Serum |
873 (36,4) | – | 31023-5 | – | › | |||
| 24611 | Anti-Mazelen IgG | Serum |
3× per week | 58 (2,4) | B | 7962-4 IU/L | 7962-4 mIU/mL | › | ||
| 23354 | Anti-MOG (1/1) Myeline oligodentrocyte glycoproteïne antistoffen (1/1) | Lumbaalvocht (CSV) |
1× per 1–2 weken | 112 (4,7) | – | 91543-9 | – | › | ||
| 23304 | Anti-MOG (1/10) Myeline oligodentrocyte glycoproteïne antistoffen (1/10) | Serum |
1× per 1–2 weken | 46 (1,9) | – | 106548-1 | – | › | ||
| 23353 | Anti-MOG titer | Serum |
149 (6,2) | – | 84873-9 | – | › | |||
| 23355 | Anti-MOG titer | Lumbaalvocht (CSV) |
– | – | – | › | ||||
| 25054 | Anti-Müllerian Hormoon | Serum |
maandag t/m vrijdag | 23 (1) | B | 38476-8 ng/mL | – | › | ||
| 3277 | anti-MuSK As Anti-muscle specific kinase antistoffen | Serum |
278 (11,6) | – | 94273-0 | – | › | |||
| 3313 | Anti-nucleosomen | Serum |
– | 53014-7 U/ml | – | › | ||||
| 24185 | Anti-Tetanus Toxoid IgG | Serum |
1× per week | 177 (7,4) | – | – IU/mL | – | › | ||
| 24948 | Anti-thyroglobuline As Anti-TG antistoffen, Colloïd antistoffen, Thyreoglobuline antistoffen | Serum |
maandag t/m vrijdag | 5 (0,2) | B | 8098-6 IU/mL | – | › | ||
| 24952 | Anti-TPO As | Serum |
maandag t/m vrijdag | – | 8099-4 IU/mL | – | › |
